Novavax to Host 3rd Annual Analyst and Investor Meeting
September 29 2015 - 6:55AM
Novavax, Inc., (Nasdaq:NVAX) a clinical-stage vaccine company
focused on the discovery, development and commercialization of
recombinant nanoparticle vaccines and adjuvants, will host its 3rd
annual Analyst and Investor Meeting today, Tuesday, September 29,
2015 from 9:00 a.m. – 11:00 a.m. ET in New York, NY.
Senior management will conduct a series of
presentations to update analysts and investors on the Company’s
ongoing clinical development programs, as well as provide
additional information about the maternal immunization program and
the Bill & Melinda Gates Foundation grant. In addition, a key
opinion leader will provide a clinical perspective on respiratory
syncytial virus (RSV) disease.
For additional information and registration,
please email novavax@westwicke.com or call 443-213-0506.
A live webcast of the presentations can be
accessed at the following link:
http://edge.media-server.com/m/p/en8imvms
Please allow extra time prior to the webcast to
visit the site and download the streaming media software required
to listen to the Internet broadcast. The webcast and a replay of
the presentation will also be accessible under the
“Investors/Events” section of the Novavax website at
novavax.com. The event will be archived on the company's
website for 90 days.
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage
vaccine company committed to delivering novel products to prevent a
broad range of infectious diseases. Our recombinant nanoparticles
and Matrix-M™ adjuvant technology are the foundation for
groundbreaking innovation that improves global health through safe
and effective vaccines. Additional information about Novavax is
available on the company’s website, novavax.com.
Contact:
Novavax, Inc.
Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer
Andrea N. Flynn, Ph.D.
Senior Manager, Investor Relations
ir@novavax.com
240-268-2000
Russo Partners, LLC
David Schull
Todd Davenport, Ph.D.
david.schull@russopartnersllc.com
todd.davenport@russopartnersllc.com
212-845-4271
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Sep 2023 to Sep 2024